# ROMVIMZA
> **NDA219304** · New Drug Application · Sponsor: DECIPHERA PHARMS · Approved 2025-02-14
## Drug
- **FDA Application Number:** NDA219304
- **Application type:** New Drug Application
- **Brand name:** ROMVIMZA
- **Generic name:** VIMSELTINIB
- **Active ingredients:** VIMSELTINIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** DECIPHERA PHARMS
- **Manufacturer:** Deciphera Pharmaceuticals, LLC
- **First approval:** 2025-02-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219304)
---
*AI Analytics · CC0 1.0*